Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Viral Clearance Market Set To Climb From $1.11 Billion In 2026 To $2.05 Billion By 2030
The viral clearance market size has experienced rapid growth in recent years. It is forecast to expand from $0.96 billion in 2025 to $1.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.7%. The historical period’s expansion is attributable to limited viral clearance technologies, increasing viral contamination concerns in biologics, reliance on conventional filtration methods, growing regulatory scrutiny, and the expansion of pharmaceutical and biotech manufacturing pipelines.
The viral clearance market is projected to experience substantial expansion in the coming years, forecast to reach a size of $2.06 billion by 2030, achieving a compound annual growth rate (CAGR) of 16.4%. This growth during the projection period can be ascribed to several factors, including the emergence of advanced viral inactivation techniques, greater acceptance of nanofiltration and membrane chromatography, an increase in the production of biologics and gene therapies, the incorporation of automation into viral clearance processes, and enhanced investment in developing viral detection assays. Key trends anticipated during the same period involve a wider embrace of sophisticated viral detection and inactivation technologies, a growing need for secure, virus-free vaccines and therapeutic products, the expansion of cellular and gene therapy products necessitating viral clearance, the incorporation of high-efficiency filtration and nanofiltration techniques, and an increased reliance on contract research organizations for outsourced viral clearance services.
Get A Free Sample Report With In-Depth Market Insights:
Viral Clearance Market Growth Catalysts And Demand Drivers
The increasing incidence of chronic diseases is anticipated to propel the growth of the viral clearance market moving forward. Chronic diseases are enduring medical conditions that develop gradually and persist for months or years, often necessitating continuous care or management. Globally, the prevalence of chronic diseases is on the rise, primarily driven by an aging population, as individuals live longer due to advancements in healthcare and living standards, leading to an increase in age-related conditions such as cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance is essential in the development of biologics and gene therapies utilized to address chronic diseases, ensuring their safety and effectiveness. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the expanding prevalence of chronic diseases is driving the growth of the viral clearance market.
Viral Clearance Market Segment Analysis: What Are The Core Market Categories?
The viral clearance market covered in this report is segmented –
1) By Method: Viral Clearance Method, Viral Removal Method, Viral Inactivation Method, Viral Detection Method
2) By Application: Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Tissue And Tissue Products, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users
Subsegments:
1) By Viral Clearance Method: Downstream Processing, Filtration, Chromatography, Precipitation, Nanofiltration
2) By Viral Removal Method: Membrane Chromatography, Depth Filtration, Nanofiltration, Ultrafiltration, Protein A Affinity Chromatography
3) By Viral Inactivation Method: Solvent Detergent Method, Low pH Treatment, Heat Treatment (Pasteurization), UV-C Irradiation, Caprylate Treatment
4) By Viral Detection Method: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Nucleic Acid Testing (NAT), Cell-Based Assays, Transmission Electron Microscopy (TEM)
Viral Clearance Market Trends Shaping Long-Term Demand
Leading firms within the viral clearance market are concentrating on creating advanced offerings, including next-generation virus removal filters, aiming to boost viral safety and streamline biopharmaceutical manufacturing processes. These advanced virus removal filters represent sophisticated filtration mechanisms engineered to effectively eliminate viruses from biopharmaceutical items, thereby contributing to product integrity, accelerating filtration rates, and fostering greater output in drug production. An illustrative example is Asahi Kasei Medical Co., Ltd., a Japanese medical and bioprocess solutions provider, which introduced its advanced Planova FG1 virus-removal filter in October 2024. This filter provides approximately seven-times greater flux compared to Planova BioEX, leading to reduced filtration durations, a diminished risk of virus breakthrough, and sustained robust protein and virus-removal capability without needing a prefilter. The FG1 is compatible with typical CIP/SIP procedures and has commenced mass production in smaller dimensions, with plans for larger versions to facilitate scale-up, allowing biomanufacturers to achieve enhanced throughput and quicker cycle times.
Viral Clearance Market Top Companies Driving Competitive Growth
Major companies operating in the viral clearance market are Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Nelson Labs, Pall Corporation, Sartorius AG, Creative Biolabs, Texcell SA, Vironova AB.
View The Full Viral Clearance Market Report:
Viral Clearance Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the viral clearance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral clearance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
